BOSTON SCIENTIFIC CORP
Boston Scientific Corporation (BSC) is an American biotechnology and biomedical engineering firm and multinational manufacturer of medical devices used in interventional medical specialties, including interventional radiology, interventional cardiology, peripheral interventions, neuromodulation, neurovascular intervention, electrophysiology, cardiac surgery, vascular surgery, endoscopy, oncology, urology and gynecology.
Basic company information
Each field links to its source. Financial figures retain their reporting periods; background references are identified in the source list.
- Ticker / security symbols
- BSX [1]
- Listing exchanges
- NYSE [1]
- SEC industry
- Surgical & Medical Instruments & Apparatus [1]
- Business sectors
- interventional radiology; electrophysiology; medical device; neuromodulation; interventional cardiology [2]
- Company / filing name
- BOSTON SCIENTIFIC CORP [1]
- Headquarters location
- Marlborough [2]
- Business address
- 300 BOSTON SCIENTIFIC WAY, MARLBOROUGH, MA, 01752-1234 [1]
- Founded
- 1979-06-29 [2]
- Legal form
- Delaware corporation [2]
- Incorporation jurisdiction
- Delaware, United States [1]
- Founders
- John Abele; Peter Nicholas [2]
- Official website
- www.bostonscientific.com ↗ [2]
- Fiscal year end
- December 31 (SEC record) [1]
- ISIN (reported securities)
- US1011371077 [2]
- CIK
- 0000885725 [1]
- SIC code
- 3841 [1]
- Country in background record
- United States [2]
Company positioning and business
Boston Scientific Corporation (BSC) is an American biotechnology and biomedical engineering firm and multinational manufacturer of medical devices used in interventional medical specialties, including interventional radiology, interventional cardiology, peripheral interventions, neuromodulation, neurovascular intervention, electrophysiology, cardiac surgery, vascular surgery, endoscopy, oncology, urology and gynecology. [3]
The company is known for developing the Taxus Stent, a drug-eluting stent that is used to open clogged arteries. [3]
BSC is headquartered in Marlborough, Massachusetts and incorporated in Delaware. [3]
Background text: Wikipedia contributors, Boston Scientific. Selected introductory paragraphs, licensed under CC BY-SA 4.0. Official filing data is cited separately.
Financial year, securities and disclosures
The SEC submissions record gives BOSTON SCIENTIFIC CORP a fiscal year end of 1231 (MMDD). Individual filings below identify their own reporting period; the filing date is the publication event, not the financial year end. [1]
Listed securities: BSX (NYSE). Multiple symbols may represent different share classes or securities of the same registrant. [4]
History and key events
Financial results and regulatory disclosures
Annual, quarterly and current reports from the collected SEC record. Insider Forms 4 and 144 are excluded. This is a selected list, not a live filing feed.
Source-verified relationships
Companies in the same industry
Comparison candidates share the SEC SIC classification 3841. This does not imply ownership, partnership or trading relationships.
Related entities and concepts
Frequently asked questions
When was BOSTON SCIENTIFIC CORP founded?
Founded: 1979-06-29. The linked source provides the background record. [2]
Where is the headquarters of BOSTON SCIENTIFIC CORP?
Headquarters location: Marlborough. The linked source provides the background record. [2]
Which business sectors are recorded for BOSTON SCIENTIFIC CORP?
Business sectors: interventional radiology; electrophysiology; medical device; neuromodulation; interventional cardiology. The linked source provides the background record. [2]
BOSTON SCIENTIFIC CORP relationship map
Select a node to inspect its relationship and source.
2 verified direct relationships. Industry peers are not relationship edges.
Sources and review dates
- SEC — BOSTON SCIENTIFIC CORP filing identity and securities ↗
- Wikidata — company background record (CC0) ↗
- Wikipedia contributors — Boston Scientific (CC BY-SA 4.0) ↗
- SEC securities directory ↗
- Company chronology / filing ↗
Reviewed 23 October 2026. Financial periods and historical event dates are shown separately. Figures reflect their stated source dates; this page is not a live quote or investment recommendation.